Exploiting Cancer Cell Signaling and Metabolism: Implications for Therapeutic Approach

Suman Mukhopadhyay(NYU Langone Health)

CUNY Academic Works (City University of New York)

January 1, 2015

10.13140/rg.2.1.4721.3848

Cited by 0

Related Papers

Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer

|Cancer Cell|2024|115

Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy

|Cancer Research|2023|102

Adeno-to-squamous transition drives resistance to KRAS inhibition in <i>LKB1</i> mutant lung cancer

|bioRxiv (Cold Spring Harbor Laboratory)|2023|1